Tilray is a Canadian pharmaceutical and cannabis company, headquartered in Toronto with operations in multiple regions. It has recently acquired BrewDog for £33m, a move that followed BrewDog’s sale to Tilray and a leadership shift earlier this year.
James Watt has tabled a public bid to buy back BrewDog through Second Best, pledging to restore equity to Equity for Punks investors and reinstate living wages as Tilray’s takeover earlier this year precipitated job losses and bar closures.